Picture of Molecular Templates logo

MTEMQ — Molecular Templates News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Molecular Templates Inc reports results for the quarter ended in September - Earnings Summary

* Molecular Templates Inc  MTEM.OQ  reported a quarterly
adjusted
loss of 44 cents​​ per share for the quarter ended in September.
The mean expectation of seven analysts for the quarter was for a
loss of 48 cents per share.
    * Revenue rose 78.2% to $4.24 million from a year ago;
analysts
expected $3.30 million. 
    * Molecular Templates Inc's reported EPS for the quarter was
a
loss of 44 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Molecular Templates Inc shares had fallen by 20.0% this
quarter and lost 84.7% so far this year.
    * The company reported a quarterly loss of $24.64 million.
    * Wall Street's median 12-month price target for Molecular
Templates Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.48          -0.44          Beat
 Jun. 30 2022      -0.48          -0.44          Beat
 Mar. 31 2022      -0.47          -0.38          Beat
 Dec. 31 2021      -0.40          -0.18          Beat

Recent news on Molecular Templates

See all news